以岭药业官网 | 血鸟导航

中文	英文	栏目
首页	Home	Home
关于以岭	About Yiling	About Yiling
以岭概况	Overview of Yiling	Overview
创始人介绍	Introduction of Founder	Founder Introduction
董事长介绍	Introduction of Chairman	Chairman Introduction
荣誉殿堂	Hall of Fame	Hall of Fame
企业文化	Corporate Culture	Corporate Culture
以岭动态	Yiling Dynamics	Company News
公司要闻	Company Highlights	Company Highlights
视频中心	Video Center	Video Center
以岭公益	Yiling Public Welfare	Public Welfare
产品展示	Product Display	Product Display
创新中药	Innovative Chinese Medicine	Innovative Chinese Medicine
化药系列	Chemical Series	Chemical Series
健康产品	Health Products	Health Products
配方颗粒	Granulated Formula	Granulated Formula
投资者关系	Investor Relations	Investor Relations
基本概况	Basic Overview	Basic Overview
公司公告	Company Announcements	Company Announcements
年度报告	Annual Report	Annual Report
社会责任报告	Social Responsibility Report	Social Responsibility Report
加入我们	Join Us	Join Us
人才理念	Talent Philosophy	Talent Philosophy
校园招聘	Campus Recruitment	Campus Recruitment
社会招聘	Social Recruitment	Social Recruitment
联系我们	Contact Us	Contact Us
安全性信息反馈	Safety Information Feedback	Safety Information Feedback
企业 OA	Enterprise OA	Enterprise OA
企业邮箱	Enterprise Email	Enterprise Email
EHR	Electronic Health Record	Electronic Health Record
了解更多	Learn More	Learn More
查看更多动态	View More Dynamics	View More Dynamics
通心络治疗急性心梗研究位列2023年度中医药十大学术进展首位	Tongxinluo Treatment of Acute Myocardial Infarction Ranked First in the Top Ten Academic Progress of Traditional Chinese Medicine in 2023	Tongxinluo Treatment of Acute Myocardial Infarction Ranked First in the Top Ten Academic Progress of Traditional Chinese Medicine in 2023
【以岭论坛】聚焦冠状动脉口部病变精准介入诊疗，提升心血管病中西医结合治疗水平	[Yiling Forum] Focusing on Precise Intervention Diagnosis and Treatment of Coronary Artery Orifice Lesions, Enhancing the Level of Cardiovascular Disease Treatment by Integrating Traditional Chinese Medicine and Western Medicine	[Yiling Forum] Focusing on Precise Intervention Diagnosis and Treatment of Coronary Artery Orifice Lesions, Enhancing the Level of Cardiovascular Disease Treatment by Integrating Traditional Chinese Medicine and Western Medicine
以岭药业制剂车间获评“全国工人先锋号”	Yiling Pharmaceutical Preparation Workshop Awarded “National Pioneer of Workers”	Yiling Pharmaceutical Preparation Workshop Awarded “National Pioneer of Workers”
以岭药业：十万亩连翘种植基地成为村民致富“黄金钥匙”	Yiling Pharma: 100,000 Mu of Forsythia Planting Base Becomes the “Golden Key” to Villagers’ Wealth	Yiling Pharma: 100,000 Mu of Forsythia Planting Base Becomes the “Golden Key” to Villagers’ Wealth
中华通络操在“四川-首尔文化旅游交流会”上大放异彩	Zhonghua Tongluo Exercise Shines at the “Sichuan-Seoul Cultural and Tourism Exchange Conference”	Zhonghua Tongluo Exercise Shines at the “Sichuan-Seoul Cultural and Tourism Exchange Conference”
创立“五位一体”发展新模式	Establishing a New Development Model of “Five in One”	Establishing a New Development Model of “Five in One”
首次形成系统络病理论	First Formulation of Systematic Collateral Disease Theory	First Formulation of Systematic Collateral Disease Theory
六项国家成果奖	Six National Achievement Awards	Six National Achievement Awards
两次承担国家973项目	Undertaking the National 973 Project Twice	Undertaking the National 973 Project Twice
冀ICP备12020237号-5	Hebei ICP Prepared No. 12020237-5	Hebei ICP Prepared No. 12020237-5
河北以岭医院	Hebei Yiling Hospital	Hebei Yiling Hospital
以岭健康	Yiling Health	Yiling Health
疑难病杂志社	Journal of Difficult and Complicated Diseases	Journal of Difficult and Complicated Diseases

域名信息

注册人/机构：石家庄以岭药业股份有限公司

注册人邮箱：****8599@qq.com

域名年龄：19年1个月18天（过期时间为2025年03月10日)
备案信息

备案号：冀ICP备12020237号

名称：石家庄以岭药业股份有限公司

性质：企业

审核时间：2022-06-06
网站信息

IP：40.73.32.115[中国北京北京微软云]

数据统计

数据评估

以岭药业热度已经达到26；以上网站数据仅供参考，建议大家以官方数据为准！更多以岭药业数据如：访问速度、搜索引擎收录以及索引量、用户体验、品牌价值观等；请联系以岭药业的官方提供。如该站的IP、PV、跳出率等！

特别声明

本站血鸟导航提供的以岭药业相关数据内容都来源于网络或站长收集，不保证外部链接和内容的准确性和完整性，同时，对于该外部链接的指向，不由血鸟导航实际控制，在2024年5月8日上午11:55收录时，该网页上的内容，都属于合规合法，后期网页的内容如出现违规或不对称，欢迎联系我们邮箱进行删除或更改，血鸟导航不承担任何责任。

血鸟导航致力于帮助广大用户，精准快捷的找到需要的网站！本文地址https://www.xieniao.com/sites/135464.html转载请注明